Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹915 Cr₹997 Cr₹364 Cr₹791 Cr₹605 Cr

What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Operating Activities ratio of GLAND PHARMA is ₹915 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹915 Cr
Mar2024₹997 Cr
Mar2023₹364 Cr
Mar2022₹791 Cr
Mar2021₹605 Cr

How is Cash Flow from Operating Activities of GLAND PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹915 Cr
-8.23
Mar2024 ₹997 Cr
173.87
Mar2023 ₹364 Cr
-53.97
Mar2022 ₹791 Cr
30.72
Mar2021 ₹605 Cr -

Compare Cash Flow from Operating Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹29,328.6 Cr -5.6% 1.5% 19.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,431.0 Cr -0.4% -0.1% -2% Stock Analytics
DIVIS LABORATORIES ₹163,772.0 Cr 0.9% -3% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,884.0 Cr 2% 1.7% 25.2% Stock Analytics
CIPLA ₹107,503.0 Cr -0.9% -7.2% -9.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,798.0 Cr -0.6% 6.8% 2.7% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-5.6%

1.5%

19.7%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses